SCHEMBL1094348

SCHEMBL1094348

Oc1ccc(Cl)cc1-c1ccnc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.49
EPHX2 P34913 1/20 0.47
IDO1 P14902 7/20 0.46
CYP19A1 P11511 1/20 0.46
TLR8 Q9NR97 1/20 0.46
MEN1 O00255 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HSP90AA1 P07900 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PLA2G1B P04054 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
HIF1A Q16665 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319626 0.83 DYRK1A (0.55) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL16094054 0.80 KMO (0.54) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL17293776 0.80 SHMT1 (0.46) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL3626709 0.80 RORB (0.49) IDO1MEN1HPGDKMT2AHSD17B10
SCHEMBL1423572 0.79 PIM1 (0.53) PIM1EPHX2IDO1CYP19A1MEN1
SCHEMBL1094766 0.79 MYC (0.44) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL1743707 0.79 DYRK1A (0.44) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL1093987 0.79 DYRK1A (0.44) PIM1EPHX2IDO1CYP19A1TLR8
SCHEMBL1094682 0.79 ERN1 (0.45) PIM1EPHX2IDO1CYP19A1TLR8
Hydrochloric Acid SCHEMBL17293618 0.79 KMO (0.53) PIM1EPHX2IDO1CYP19A1TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385938-B1 SULFONAMIDE DERIVATIVES PFIZER LTD (GB) 2015-03-04 EP disclosed
US-8907101-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2014-12-09 US disclosed
US-20130338111-A1 Sulfonamide Derivatives ICAGEN, INC. (US) 2013-12-19 US disclosed
US-8541588-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2013-09-24 US disclosed
US-20120149679-A1 Sulfonamide Derivatives ICAGEN, INC. 2012-06-14 US disclosed
US-8153814-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2012-04-10 US disclosed
CN-102348697-A Sulfonamide derivatives PFIZER LTD 2012-02-08 CN disclosed
EP-2385938-A1 SULFONAMIDE DERIVATIVES Pfizer Limited (GB) 2011-11-16 EP disclosed
US-8040476-B2 Display device and method of producing the same MITSUBISHI ELECTRIC CORPORATION (JP) 2011-10-18 US disclosed
US-20100197655-A1 SULFONAMIDE DERIVATIVES Pfizer Limited Icagen, Inc. 2010-08-05 US disclosed
WO-2010079443-A1 SULFONAMIDE DERIVATIVES PFIZER LIMITED (GB) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197655-A1 SULFONAMIDE DERIVATIVES SULT2A1, SULT1A1, TPST2 PIM1 1972/4885EPHX2 2403/4885IDO1 3477/4885
US-20130338111-A1 Sulfonamide Derivatives SULT2A1, SULT1A1, TPST2 PIM1 1972/4885EPHX2 2403/4885IDO1 3477/4885
US-20120149679-A1 Sulfonamide Derivatives SULT2A1, SULT1A1, TPST2 PIM1 1972/4885EPHX2 2403/4885IDO1 3477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.